US stocks suffered their worst week in recent memory after a poor report on the Chinese economy sparked broader anxiety about emerging economies and whether equities are overvalued.
The deepest decline came in the Dow Jones Industrial Average, which fell 579.45 points (3.52 percent) to 15,879.11 in the biggest weekly loss in percent terms since November 2011.
The broad-based S&P 500 fell 48.41 (2.63 percent) to 1,790.29, while the tech-rich NASDAQ Composite Index declined 69.41 (1.65 percent) to 4,128.17.
This week’s bruising finale raised the issue of a market correction to the top of the agenda.
After the S&P 500 surged nearly 30 percent last year, equity markets have largely meandered through the first part of the new year on loose confidence that the US economic recovery was on track. However, stocks plunged on Thursday after HSBC’s China manufacturing sector purchasing managers index (PMI) fell to 49.6, below the 50 line between growth and contraction. US Treasury prices also rose, while emerging-economy currencies plummeted.
Stocks continued to fall on Friday, suggesting broader investor discomfort.
“It may be that if anyone is looking for reasons to sell, they can always find reasons to sell,” BMO Private Bank chief investment officer Jack Ablin said, referring China’s PMI report.
Ablin said the market was probably overvalued, citing estimates that the stock market was overvalued by 10 to 20 percent.
“There is a real reassessment going on on the street that things might have really gotten carried away last year,” Marblehead Asset Management director Mace Blicksilver said.
“The market is in a dangerous position because we have not really had a correction in a long time,” Blicksilver said, characterizing the recent round of corporate earnings as “okay,” but no better.
The results to date have seen a few standout winners, like online video service Netflix, which posted a big increase in subscriptions, and Microsoft, which notched record revenues thanks to strong demand for Xbox consoles and other products.
However, Wall Street punished IBM after it posted its seventh straight quarter of declining revenues. Even more typical was the reaction to Johnson & Johnson, which fell after giving a disappointing outlook even as it bested earnings expectations.
“I was hopeful that fundamentals would pick up,” Ablin said. “But so far, earnings season, while reasonable, hasn’t been a huge positive surprise.”
Ventural Wealth Management portfolio strategist Tom Cahill said equity markets were jittery in light of the steep declines in recent days in the Argentine peso and other emerging-market currencies.
“The situation that is emerging right now with the currencies in South America and other emerging markets is significant enough that it could lead to further downside in the near term in the equities,” Cahill said.
The drop in emerging-market currencies has added to speculation on whether next week’s policy meeting of the US Federal Reserve will result in a decision to continue to scale back stimulus, analysts said.
Cahill said this week’s volatility could persuade Fed officials of the need to “move ahead very carefully” with the taper, but other analysts expect the US central bank to stay the course and proceed with further reducing bond purchases.
Investors will also wade through a busy week of economic data, which include the Case-Shiller index of home prices, the Conference Board’s report on consumer confidence and the first estimate of fourth-quarter GDP.
The calendar of corporate earnings include reports from giants like Apple, Pfizer, Boeing, Caterpillar, ExxonMobil, Facebook and Google.
Traders could see individual stocks lifted or depressed by an ongoing wave of shareholder activism that shows no sign of abating.
Last week, Third Point disclosed a campaign to shake up Dow Chemical, while longtime corporate raider Carl Icahn pressed ahead with campaigns to win a large share buyback from Apple and the spinoff of eBay’s PayPal unit.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained